수의용 백신 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Veterinary Vaccine Market size is expected to reach USD 15.24 Billion in 2034 from USD 9.34 Billion (2025) growing at a CAGR of 5.59% during 2026-2034.

The Global Veterinary Vaccine Market has expanded significantly due to increasing awareness of animal health and the rising incidence of zoonotic diseases. Livestock production growth and the need to prevent infectious diseases in poultry, cattle, and swine have fueled vaccine demand. Companion animal ownership has also surged globally, encouraging preventive healthcare measures. Governments and international organizations actively promote vaccination programs to ensure food safety and public health protection.

Market growth is driven by technological advancements in vaccine development, including recombinant and DNA-based vaccines. Increased investment in veterinary research and the expansion of animal husbandry industries further stimulate demand. Growing export activities of animal-derived products require strict health compliance, reinforcing vaccination adoption. Additionally, rising disposable incomes and willingness to spend on pet healthcare contribute to the steady expansion of the companion animal vaccine segment.

The market's future outlook remains robust, supported by innovations in multivalent vaccines and improved cold chain logistics. Expanding livestock industries in emerging economies will offer substantial opportunities. Public-private partnerships and government-led immunization campaigns are expected to strengthen market penetration. As global focus on food security and zoonotic disease prevention intensifies, veterinary vaccines will continue to play a vital role in sustainable animal health management.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• Attenuated Live Vaccines Technology
• Inactivated Vaccines Technology
• Subunit Vaccines Technology
• Toxoid Vaccines Technology
• Dna Vaccines Technology

By Animal

• Companion Animals
• Livestock Animals
• Aquaculture

By Disease Indication

• Foot And Mouth Disease (FMD)
• Newcastle Disease
• Porcine Reproductive and Respiratory Syndrome (PRRS)
• Canine Parvovirus
• Brucellosis
• Avian Influenza
• Others

By Distribution Channel

• Veterinary Hospital Pharmacies
• Veterinary Clinics
• Retail Pharmacies
• Online Pharmacies

COMPANIES PROFILED

• Merck Co Inc MSD Animal Health, Zoetis Services LLC, Boehringer Ingelheim International GmbH and Elanco Eli Lilly, Ceva, Kemin Industries Inc, Virbac, Jinyu Biotechnology Co Ltd, Vaxxinova, Indian Immunologicals Ltd, Phibro Animal Health Corporation and Others

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL VETERINARY VACCINE MARKET: BY TECHNOLOGY 2022-2034 (USD MN and Million Doses)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. Attenuated Live Vaccines Technology Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 4.3. Inactivated Vaccines Technology Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 4.4. Subunit Vaccines Technology Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 4.5. Toxoid Vaccines Technology Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 4.6. Dna Vaccines Technology Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 5. GLOBAL VETERINARY VACCINE MARKET: BY ANIMAL 2022-2034 (USD MN and Million Doses)

• 5.1. Market Analysis, Insights and Forecast Animal
• 5.2. Companion Animals Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 5.3. Livestock Animals Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 5.4. Aquaculture Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 6. GLOBAL VETERINARY VACCINE MARKET: BY DISEASE INDICATION 2022-2034 (USD MN and Million Doses)

• 6.1. Market Analysis, Insights and Forecast Disease Indication
• 6.2. Foot And Mouth Disease (FMD) Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 6.3. Newcastle Disease Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 6.4. Porcine Reproductive and Respiratory Syndrome (PRRS) Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 6.5. Canine Parvovirus Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 6.6. Brucellosis Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 6.7. Avian Influenza Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 6.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 7. GLOBAL VETERINARY VACCINE MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN and Million Doses)

• 7.1. Market Analysis, Insights and Forecast Distribution Channel
• 7.2. Veterinary Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 7.3. Veterinary Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 7.4. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 7.5. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 8. GLOBAL VETERINARY VACCINE MARKET: BY REGION 2022-2034(USD MN and Million Doses)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
  • 8.2.1 By Technology
  • 8.2.2 By Animal
  • 8.2.3 By Disease Indication
  • 8.2.4 By Distribution Channel
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
  • 8.3.1 By Technology
  • 8.3.2 By Animal
  • 8.3.3 By Disease Indication
  • 8.3.4 By Distribution Channel
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
  • 8.4.1 By Technology
  • 8.4.2 By Animal
  • 8.4.3 By Disease Indication
  • 8.4.4 By Distribution Channel
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
  • 8.5.1 By Technology
  • 8.5.2 By Animal
  • 8.5.3 By Disease Indication
  • 8.5.4 By Distribution Channel
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
  • 8.6.1 By Technology
  • 8.6.2 By Animal
  • 8.6.3 By Disease Indication
  • 8.6.4 By Distribution Channel
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL VETERINARY VACCINE INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Merck & Co. Inc. (MSD Animal Health)
  • 10.2.2 Zoetis Services LLC
  • 10.2.3 Boehringer Ingelheim International GmbH And Elanco (Eli Lilly)
  • 10.2.4 Ceva
  • 10.2.5 Kemin Industries Inc
  • 10.2.6 Virbac
  • 10.2.7 Jinyu Biotechnology Co. Ltd
  • 10.2.8 Vaxxinova
  • 10.2.9 Indian Immunologicals Ltd
  • 10.2.10 Phibro Animal Health Corporation And Others